Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia

被引：0
|
作者：
Song-Yau Wang
Thomas Ebert
Nadja Jaekel
Stefan Schubert
Dietger Niederwieser
Haifa Kathrin Al-Ali
机构：
[1] University Hospital of Leipzig,Division of Hematology and Oncology
[2] University Hospital of Leipzig,Department of Endocrinology and Nephrology
[3] University Hospital of Leipzig,Division of Infectious Diseases and Tropical Medicine, Department of Gastroenterology and Rheumatology
[4] University of Leipzig,Division of Hematology and Oncology
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Stem Cell Transplantation; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia Patient; Ibrutinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1419 / 1420
页数：1
相关论文
共 50 条
  • [1] Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia
    Wang, Song-Yau
    Ebert, Thomas
    Jaekel, Nadja
    Schubert, Stefan
    Niederwieser, Dietger
    Al-Ali, Haifa Kathrin
    ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1419 - 1420
  • [2] Ibrutinib for Chronic Lymphocytic Leukemia
    Rigolin, Gian Matteo
    Cavazzini, Francesco
    Cuneo, Antonio
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1593 - 1593
  • [3] Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
    Jain, Preetesh
    Keating, Michael
    Wierda, William
    Estrov, Zeev
    Ferrajoli, Alessandra
    Jain, Nitin
    George, Binsah
    James, Danelle
    Kantarjian, Hagop
    Burger, Jan
    O'Brien, Susan
    BLOOD, 2015, 125 (13) : 2062 - 2067
  • [4] Real-World Analysis of Adverse Event Rates after Initiation of Ibrutinib Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia By Ibrutinib Discontinuation Status
    De Nigris, Enrico
    Huntington, Scott F.
    Puckett, Justin
    Kamal-Bahl, Sachin
    Farooqui, Mohammed Z. H.
    Ryland, Katherine Elizabeth
    Sarpong, Eric
    Yang, Xiaoqin
    Doshi, Jalpa
    BLOOD, 2022, 140 : 5043 - 5044
  • [5] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
  • [6] Ibrutinib for treatment of chronic lymphocytic leukemia
    Vela, Cory M.
    McBride, Ali
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 367 - 375
  • [7] Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
    Neffendorf, James E.
    Gout, Irina
    Hildebrand, G. Darius
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1277 - 1277
  • [8] Ibrutinib (Imbruvica) for Chronic Lymphocytic Leukemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1440): : 29 - 30
  • [9] Ibrutinib for Chronic Lymphocytic Leukemia REPLY
    Burger, Jan A.
    Styles, Lori
    Kipps, Thomas J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1594 - 1595
  • [10] Ibrutinib Resistance in Chronic Lymphocytic Leukemia
    Furman, Richard R.
    Cheng, Shuhua
    Lu, Pin
    Setty, Menu
    Perez, Alexendar R.
    Guo, Ailin
    Racchumi, Joelle
    Xu, Guozhou
    Wu, Hao
    Ma, Jiao
    Steggerda, Susanne M.
    Coleman, Morton
    Leslie, Christina
    Wang, Y. Lynn
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2352 - 2354
12345